Journal of Cystic Fibrosis
Volume 3, Issue 2 , Pages 93-98, June 2004

Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults

  • J.M Courtney

      Affiliations

    • Adult Cystic Fibrosis Centre, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, North Ireland, UK
    • Centre for Inflammation, Queens University, Belfast, UK
  • ,
  • K.E.A Dunbar

      Affiliations

    • Centre for Inflammation, Queens University, Belfast, UK
    • Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK
  • ,
  • A McDowell

      Affiliations

    • Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK
  • ,
  • J.E Moore

      Affiliations

    • Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, UK
  • ,
  • T.J Warke

      Affiliations

    • Adult Cystic Fibrosis Centre, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, North Ireland, UK
    • Centre for Inflammation, Queens University, Belfast, UK
  • ,
  • M Stevenson

      Affiliations

    • Department of Medical Statistics, Queens University, Belfast, UK
  • ,
  • J.S Elborn

      Affiliations

    • Corresponding Author InformationCorresponding author. Adult Cystic Fibrosis Centre, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, North Ireland, UK Tel: +44-2890-329241x3683; fax: +44-2890-263546.
    • Adult Cystic Fibrosis Centre, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, North Ireland, UK
    • Centre for Inflammation, Queens University, Belfast, UK

Received 2 January 2003; accepted 28 January 2004.

Abstract 

Background: The Burkholderia cepacia complex (BCC) is one of the most important groups of organisms infecting cystic fibrosis (CF) patients. The aim of the study was to examine how infection with BCC affects clinical outcome. Methods: Nineteen CF adults infected with BCC and 19 controls infected with Pseudomonas aeruginosa were studied over a 4-year period. The best forced expiratory volume in 1 s (FEV1) and body mass index (BMI) for each year were recorded and annual rate of decline calculated. Results: The BCC infected group displayed a significantly greater reduction of FEV1 and BMI compared to the P. aeruginosa infected group (p=0.001 and p=0.009, respectively). Sixteen patients infected with a single Burkholderia cenocepacia strain had a significantly greater rate of FEV1 decline compared to those infected with Burkholderia multivorans (n=3) or P. aeruginosa (p=0.01 and p<0.0001, respectively). The rate of BMI decline was significantly greater in patients infected with B. cenocepacia compared to those with P. aeruginosa (p=0.007), but not significantly different in those with B. multivorans (p=0.29). Conclusion: BCC infection is associated with an accelerated decline in pulmonary function and BMI. Infection with a single B. cenocepacia strain was associated with a more rapid decline in lung function than those infected with either B. multivorans or P. aeruginosa.

Keywords:  Cystic fibrosis, Gram negative infection, Clinical outcome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Grant support—Research and Development Project Grant, North–South Co-operation.

PII: S1569-1993(04)00032-3

doi:10.1016/j.jcf.2004.01.005

Journal of Cystic Fibrosis
Volume 3, Issue 2 , Pages 93-98, June 2004